Condition
Fulminant Liver Failure
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Hepatocyte Infusion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Withdrawn1
Clinical Trials (2)
Research Network
Common Treatments
- Hepatocyte Infusion1
Active Sponsors
- Virginia Commonwealth University1
- RenJi Hospital1
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Top Investigators
Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
VCU Health System
Related Conditions
- Hepatic Tumors1
- Metabolic Disorders1
- Biliary Atresia1